Cary Street Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
28,473
-37,251
-57% -$3.51M 0.04% 359
2026
Q1
$7.77M Sell
65,724
-17,310
-21% -$2.14M 0.19% 123
2025
Q4
$10.4M Sell
83,034
-15,626
-16% -$2.04M 0.26% 88
2025
Q3
$14.4M Sell
98,660
-346
-0.3% -$52.3K 0.37% 64
2025
Q2
$15.4M Buy
99,006
+389
+0.4% +$61.7K 0.43% 56
2025
Q1
$16.2M Buy
98,617
+2,290
+2% +$381K 0.51% 47
2024
Q4
$15.7M Buy
+96,327
New +$17.2M 0.51% 50

Other funds holding ZTS

Cary Street Partners's ZTS Position: Q2 2026 in Review

Cary Street Partners reduced its Zoetis (ZTS) stake by 57% in Q2 2026, selling an estimated $3.51M and leaving 28,473 shares worth $2.05M. The position accounts for 0.04% of the portfolio, ranked #359.

Cary Street Partners first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.2M in Q1 2025. 270 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Cary Street Partners held 28,473 shares of Zoetis worth $2.05M as of Q2 2026.
  • Cary Street Partners sold 37,251 Zoetis shares in Q2 2026, an estimated $3.51M.
  • Zoetis made up 0.04% of Cary Street Partners's portfolio in Q2 2026, its #359 holding.
  • Cary Street Partners first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Zoetis position peaked at $16.2M in Q1 2025.
  • 270 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.